ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Invasive pneumococcal disease incidence among adults aged ≥65 years, by pneumococcal serotype* — United States, 1998-2017

Invasive pneumococcal disease incidence among adults aged ≥65 years, by pneumococcal serotype* — United States, 1998-2017
IPD: invasive pneumococcal disease; PCV7: 7-valent pneumococcal conjugate vaccine (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F); PCV13: 13-valent pneumococcal conjugate vaccine (PCV7 serotypes plus 1, 3, 5, 6A, 19A, and 7F).
* Serotype 6C showed cross-protection from 6A antigen in PCV13 and was grouped with PCV13 serotypes for IPD.
Reproduced from: Matanock A, Lee G, Gierke R, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: Updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2019; 68:1069.
Graphic 126200 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟